Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Sales | 0 | 57 | 0 | 0 | 0 |
| Gross Profit | N/A | 57 | N/A | N/A | N/A |
| Operating Expenses | 90,567 | 72,803 | 32,857 | 21,589 | 0 |
| Operating Income | -90,567 | -72,746 | -32,857 | -21,589 | N/A |
| Interest Expense | 977 | 794 | 330 | 0 | 0 |
| Other Income | 3,467 | 2,648 | 712 | 1,165 | 0 |
| Pre-tax Income | -88,077 | -70,892 | -32,475 | -20,424 | 0 |
| Income Tax | 3 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -88,080 | -70,892 | -32,475 | -20,424 | N/A |
| Net Income | $-88,080 | $-70,892 | $-32,475 | $-20,424 | $N/A |
| EPS Basic Total Ops | -1.30 | -1.10 | -2.10 | -1.49 | N/A |
| EPS Basic Continuous Ops | -1.30 | -1.08 | -1.64 | -1.03 | N/A |
| EPS Diluted Total Ops | -1.30 | -1.10 | -2.10 | -1.49 | N/A |
| EPS Diluted Continuous Ops | -1.30 | -1.08 | -1.64 | -1.03 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.30 | -1.08 | -2.10 | N/A | N/A |
| EBITDA(a) | $-82,047 | $-65,705 | $-29,548 | $-20,834 | $N/A |